Surface modification of polyethylene balloon catheters for local drug delivery

被引:67
作者
Richey, T
Iwata, H
Oowaki, H
Uchida, E
Matsuda, S
Ikada, Y
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Kyoto 606, Japan
[2] Kacho Jr Coll, Kyoto 6120062, Japan
基金
日本学术振兴会; 美国国家科学基金会;
关键词
percutaneous transluminal angioplasty; balloon catheter; thrombin local drug delivery;
D O I
10.1016/S0142-9612(99)00281-1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Local drug delivery is an attractive approach to the associated problems of percutaneous transluminal coronary angioplasty (PTCA), including arterial injury. The objective of the present research was to deliver a high concentration of a potent anti-thrombin agent, argatroban (ARG), to the vessel wall in order to reduce arterial injury. Local delivery was accomplished by the ionic attachment of drug particles to a modified balloon surface. Surface graft polymerization of ionic monomers to a high-density poly(ethylene) (PE) substrate was performed utilizing ultra-violet (UV) methods. Acrylic acid (AAc) and 2(dimethylamino) ethyl methacrylate (DMAEMA) were successfully grafted onto PE surfaces. Surface grafting was verified by contact angle, X-ray photoelectron spectroscopy, and zeta potential measurements. The amount of ARG adsorbed onto the modified PE surface was highly dependent on the pH of the drug media for both anionic and cationic grafted monomers. The efficacy of local drug delivery to the arterial wall was analyzed using drug-immobilized PE balloon catheters in the rabbit common carotid artery model. High concentrations of ARG (280 nmol/g tissue) were found within the ballooned arterial segment immediately after angioplasty, followed by a decrease after blood flow was restored. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1057 / 1065
页数:9
相关论文
共 33 条
[1]   DECREASED PLATELET DEPOSITION AND SMOOTH-MUSCLE CELL-PROLIFERATION AFTER INTRAMURAL HEPARIN DELIVERY WITH HYDROGEL-COATED BALLOONS [J].
AZRIN, MA ;
MITCHEL, JF ;
FRAM, DB ;
PEDERSEN, CA ;
CARTUN, RW ;
BARRY, JJ ;
BOW, LM ;
WATERS, DD ;
MCKAY, RG .
CIRCULATION, 1994, 90 (01) :433-441
[2]  
BAYKAL D, 1995, AM J CARDIOL, V75, P82
[4]   EFFECT OF 18-HOUR TO 24-HOUR HEPARIN ADMINISTRATION FOR PREVENTION OF RESTENOSIS AFTER UNCOMPLICATED CORONARY ANGIOPLASTY [J].
ELLIS, SG ;
ROUBIN, GS ;
WILENTZ, J ;
DOUGLAS, JS ;
KING, SB .
AMERICAN HEART JOURNAL, 1989, 117 (04) :777-782
[5]   PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY - TOWARDS A MOLECULAR APPROACH [J].
FELDMAN, LJ ;
RIESSEN, R ;
STEG, PG .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1995, 9 (01) :8-16
[6]   A PARADIGM FOR RESTENOSIS BASED ON CELL BIOLOGY - CLUES FOR THE DEVELOPMENT OF NEW PREVENTIVE THERAPIES [J].
FORRESTER, JS ;
FISHBEIN, M ;
HELFANT, R ;
FAGIN, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (03) :758-769
[7]   LOCALIZED INTRAMURAL DRUG-DELIVERY DURING BALLOON ANGIOPLASTY USING HYDROGEL-COATED BALLOONS AND PRESSURE-AUGMENTED DIFFUSION [J].
FRAM, DB ;
ARETZ, T ;
AZRIN, MA ;
MITCHEL, JF ;
SAMADY, H ;
GILLAM, LD ;
SAHATJIAN, R ;
WATERS, D ;
MCKAY, RG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 23 (07) :1570-1577
[8]   EFFECT OF CHRONIC SUBCUTANEOUS OR INTRAMURAL ADMINISTRATION OF HEPARIN ON FEMORAL-ARTERY RESTENOSIS AFTER BALLOON ANGIOPLASTY IN HYPERCHOLESTEROLEMIC RABBITS - A QUANTITATIVE ANGIOGRAPHIC AND HISTOPATHOLOGICAL STUDY [J].
GIMPLE, LW ;
GERTZ, SD ;
HABER, HL ;
RAGOSTA, M ;
POWERS, ER ;
ROBERTS, WC ;
SAREMBOCK, IJ .
CIRCULATION, 1992, 86 (05) :1536-1546
[9]   A NEW CATHETER FOR PROLONGED LOCAL-DRUG APPLICATION [J].
GONSCHIOR, P ;
GOETZ, AE ;
HUEHNS, TY ;
HOFLING, B .
CORONARY ARTERY DISEASE, 1995, 6 (04) :329-334
[10]   Effects of locally administration of argatroban using a hydrogel-coated balloon catheter on intimal thickening induced by balloon injury [J].
Imanishi, T ;
Arita, M ;
Hamada, M ;
Tomobuchi, Y ;
Hano, T ;
Nishio, I .
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1997, 61 (03) :256-262